Reader Comments

Post a new comment on this article


Posted by alan2102 on 08 Nov 2013 at 20:42 GMT

Interesting study, which does not comfortably comport with the evidence favoring renal protective activity of ARBs, particularly telmisartan:

J Renin Angiotensin Aldosterone Syst. 2006 Dec;7(4):185-91.
Potential protective effects of telmisartan on renal function deterioration.

J Nephrol. 2011 Sep-Oct;24(5):569-80. doi: 10.5301/JN.2011.6445.
Renal protection with angiotensin receptor blockers: where do we stand.

J Hypertens. 2006 Jan;24(1):11-25.
Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.

Int J Cardiol. 2012 May 3.
Effects of telmisartan on proteinuria or albuminuria: A meta-analysis of randomized trials.

No competing interests declared.